Department of Animal Nutrition and Feed Science, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, 430070, China; The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, 430070, Hubei, China; Hubei Provincial Engineering Laboratory for Pig Precision Feeding and Feed Safety Technology, Wuhan, 430070, Hubei, China.
Department of Animal Nutrition and Feed Science, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, 430070, China; The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, 430070, Hubei, China; Hubei Provincial Engineering Laboratory for Pig Precision Feeding and Feed Safety Technology, Wuhan, 430070, Hubei, China.
Biomed Pharmacother. 2020 Mar;123:109720. doi: 10.1016/j.biopha.2019.109720. Epub 2019 Dec 26.
Cortex Phellodendri extract (CPE) has been used in China to treat diarrhea whereas the underlying mechanisms remain poorly understood. Given that dysbiosis of gut microbiota is a potential reason for diarrhea, and that oral CPE has a low absorption rate in intestine, we hypothesized that modification of gut microbiota is an important factor in CPE's anti-diarrhea effect. To test this hypothesis, we established a diarrhea model by challenging post-weaning mice with oral Enterotoxigenic-Escherichia coli (ETEC), and then the mice were treated with two doses of CPE (80 mg/kg bodyweight and 160 mg/kg bodyweight) or the vehicle control (phosphate buffered saline). Diarrhea indices, inflammatory factors, morphology of jejunum, short-chain fatty acids (SCFAs), and serum endocrine were determined. Modification of gut microbiota was analyzed using 16S rDNA high-throughput sequencing. The changes in functional profiles of gut microbiota were predicted using software PICRUSt. We then explored the association between CPE-responding bacteria and the symptoms indices with the spearman's rank correlation coefficient and significance test. Compared with diarrheal mice, CPE decreased Gut/Carcass ratio and water content of stool, increased goblet cell density and villus height/crypt depth of jejunum, as well as decreased inflammatory indices (Tumour Necrosis Factor-α, Myeloperoxidase and Interleukin-1α). CPE shifted the gut microbiota significantly by increasing alpha diversity (observed species, ace, Shannon, and Simpson) and restoring the gut microbiota. CPE increased Firmicutes and decreased Bacteroidetes. The reduced genus Prevotella, Acinetobacter, and Morganella were positively associated with the diarrhea indices, whereas increased genus Odoribacter, Rikenella, and Roseburia were negatively associated with the diarrhea indices. The abundance of carbohydrate metabolism-related gene and SCFAs-producing bacteria were increased, which was evidenced by increased butyric acid and total SCFAs concentration in the caecum. Consequently, endocrine peptides glucagon-like peptide-1, epidermal growth factor, and peptide tyrosine tyrosine in serum were elevated. CONCLUSIONS: CPE shows a shift function on the gut microbiota in alleviating the diarrhea of mice in a dose-dependent manner. In addition, the microbial metabolites SCFAs may mediate CPE's anti-diarrhea effect by enhancing endocrine secretion in mice.
黄柏提取物(CPE)在中国被用于治疗腹泻,但作用机制尚不清楚。鉴于肠道微生物群的失调可能是腹泻的一个潜在原因,且口服 CPE 在肠道中的吸收率较低,我们假设肠道微生物群的改变是 CPE 抗腹泻作用的一个重要因素。为了验证这一假设,我们通过口服肠产毒性大肠杆菌(ETEC)对断奶后小鼠进行腹泻模型建立,然后用两种剂量的 CPE(80mg/kg 体重和 160mg/kg 体重)或载体对照(磷酸盐缓冲盐水)对小鼠进行治疗。测定腹泻指数、炎症因子、空肠形态、短链脂肪酸(SCFAs)和血清内分泌。采用 16S rDNA 高通量测序分析肠道微生物群的改变。采用软件 PICRUSt 预测肠道微生物群功能谱的变化。然后,我们用 Spearman 秩相关系数和显著性检验探索 CPE 响应细菌与症状指数之间的相关性。与腹泻小鼠相比,CPE 降低了肠道/胴体比和粪便含水量,增加了杯状细胞密度和空肠绒毛高度/隐窝深度,降低了炎症因子(肿瘤坏死因子-α、髓过氧化物酶和白细胞介素-1α)。CPE 通过增加 alpha 多样性(观察到的物种、ace、香农和辛普森)和恢复肠道微生物群来显著改变肠道微生物群。CPE 增加了厚壁菌门,减少了拟杆菌门。减少的普雷沃氏菌属、不动杆菌属和摩根菌属与腹泻指数呈正相关,而增加的恶臭杆菌属、理研菌属和罗氏菌属与腹泻指数呈负相关。糖代谢相关基因和产生 SCFAs 的细菌的丰度增加,这表现为盲肠中丁酸和总 SCFAs 浓度的增加。因此,血清中的肠降血糖素样肽-1、表皮生长因子和肽酪氨酸酪氨酸等内分泌肽升高。结论:CPE 以剂量依赖的方式对缓解小鼠腹泻具有转移功能。此外,微生物代谢物 SCFAs 可能通过增强小鼠内分泌分泌来介导 CPE 的抗腹泻作用。